Adults Born with Heart Disease at Risk of Type 2 Diabetes
According to a new study, children born with heart disease have a higher risk of developing Type 2 diabetes after the age of 30. The study... Read more
New Guidelines For Using Nonstatin Cholesterol-Lowering Drugs
The American College of Cardiology (ACC) has released an "Expert Consensus Decision Pathway" document on the role of nonstatin therapies for... Read more
Prevalence of Global Diabetes Seriously Underestimated
A landmark paper led by Monash University with partners in the UK and US suggests there may be more than 100 million people with diabetes globally... Read more
Artificial Intelligence: a next way forward for healthcare
Prof. Mamas A Mamas is a structural interventional cardiologist, treating patients with underlying coronary artery with percutaneous coronary intervention (PCI) in both the elective and emergency setting and undertaking Transcatheter Aortic Valve Interventions (TAVI). He is also the Associate Editor of Circulation Cardiovascular Interventions and leads... Read more
Chelsea Beecher serves as the Director of Development for the American Heart & Stroke Association in New York City. She led the launch of STEM Goes Red in New York City and received the Innovator of the Year Award in 2018 for this initiative. STEM Goes Red aims to empower young women to pursue science, technology, engineering, and math (STEM)... Read more
Robots were first used in cardiovascular medicine in the late 1990s as a part of the digital revolution . Since then, robotics have been applied to endovascular surgery, minimally invasive cardiac surgery, and interventional cardiology, to name a few fields. Robots give medical professionals the ability to diagnose, treat, and intervene more... Read more
Can Goal-Directed Therapy solve the economic burden of postsurgical complications?
How effective are less invasive or even noninvasive methods? The... Read more
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...
The CNAP® Monitor represents the next generation of noninvasive patient monitoring by merging the advantages of noninvasive, risk‐free methods with the benefits of continuity in the same accuracy as invasive standards. The advanced parameter set enables...